Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Contents
Current Drug Targets, Volume 18 - Number 3
Editorial
Editorial (Thematic Issue: Targets for Immunotherapy in Acute Leukemia)
, 18(3): 256Christopher S. Hourigan
DOI: 10.2174/1389450117999151116144835
Review Article
Antibody Based Therapies in Acute Leukemia
, 18(3): 257 - 270Nirali N. Shah
DOI: 10.2174/1389450117666160905091459
Antibody Based Therapies in Acute Leukemia
Review Article
Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells
, 18(3): 271 - 280Conrad R.Y. Cruz and Catherine M. Bollard
DOI: 10.2174/1389450117666160209143529
Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells
Review Article
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers
, 18(3): 281 - 295Elizabeth F. Krakow, Hui-Sheng Ai, Brian Shaffer, Jean-Sebastien Delisle, Kai-Xun Hu and Anthony D. Sung
DOI: 10.2174/1389450116666150304103849
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers
Review Article
Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia
, 18(3): 296 - 303Meghali Goswami and Christopher S. Hourigan
DOI: 10.2174/1389450116666150223120005
Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia
Review Article
Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
, 18(3): 304 - 314Joshua F. Zeidner and Matthew C. Foster
DOI: 10.2174/1389450116666150304104315
Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
Review Article
Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia
, 18(3): 315 - 331Hanna A. Knaus, Christopher G. Kanakry, Leo Luznik and Ivana Gojo
DOI: 10.2174/1389450116666150518095346
Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia
Review Article
Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer
, 18(3): 332 - 340Jan J. Melenhorst, Simon F. Lacey and Felipe Bedoya
DOI: 10.2174/1389450116666150825120427
Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer
Review Article
Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem
, 18(3): 341 - 362Giuseppe Lo Russo, Marianna Macerelli, Marco Platania, Nicoletta Zilembo, Milena Vitali, Diego Signorelli, Claudia Proto, Monica Ganzinelli, Rosaria Gallucci, Francesco Agustoni, Gianpiero Fasola, Filippo de Braud and Marina Chiara Garassino
DOI: 10.2174/1389450117666160502152331
Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem
Review Article
Mechanism of Action: How Nano-Antimicrobials Act?
, 18(3): 363 - 373Bushra Jamil, Habib Bokhari and Mohammad Imran
DOI: 10.2174/1389450116666151019101826
Mechanism of Action: How Nano-Antimicrobials Act?
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net